Klaus Jung
Humboldt State University
33 Papers
137 Citations
Klaus Jung is an academic researcher from Humboldt State University. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 13, co-authored 33 publications. Previous affiliations of Klaus Jung include Charité & Humboldt University of Berlin.
Chat about Author
Papers
Betaine improves the PCR amplification of GC-rich DNA sequences.
TL;DR: Betaine improves the co-amplification of the two alternatively spliced variants of the prostate-specific membrane antigen mRNA as well as the amplification of the coding cDNA region of c-jun.
603
Ratio of Free or Complexed Prostate-specific Antigen (PSA) to Total PSA: Which Ratio Improves Differentiation between Benign Prostatic Hyperplasia and Prostate Cancer?
Klaus Jung,Ulrike Elgeti,Michael Lein,Brigitte Brux,Pranav Sinha,Birgit Rudolph,Steffen Hauptmann,Dietmar Schnorr,Stefan A. Loening +8 more
TL;DR: Compared with tPSA, the fPSA/tPSA and c PSA/cPSA ratios both improve the differentiation between BPH and PCa comparably and are similarly effective in reducing the rate of unnecessary biopsies, whereas cPSA alone does not have any effect.
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer.
Klaus Jung,Carsten Stephan,Michaela Lewandowski,Silke Klotzek,Monika Jung,G. Kristiansen,M. Lein,Stefan A. Loening,Dietmar Schnorr +8 more
TL;DR: It can be concluded that plasma DNA has a limited validity as metastatic marker in PCa patients but follow-up studies combined with the investigation of tumor-related characteristics of plasma DNA would be reasonable.
102
Stability of enzymes in urine at 37°C
TL;DR: The activity of alanine aminopeptidase, alkaline phosphatase, γ-gluta-myltransferase, lactate dehydrogenase and β- N- acetyl - d - glucosaminidase in urine at 37°C was investigated by a model simulating in vivo conditions, and the stability of these urinary enzymes is influenced particularly by pH.
28
Urinary markers of malignancy.
TL;DR: The literature is reviewed and the current status of various diagnostic tests for urinary markers, including telomerase, Lewis X, BTA, NMP22 and urinary cytology in bladder tumor are discussed.
25